Long-term administration of dexfenfluramine to genetically obese (ob/ob) and lean mice: Body weight and brain serotonin changes

[1]  N. Rowland,et al.  Dexfenfluramine induces fos-like immunoreactivity in discrete brain regions in rats , 1993, Brain Research Bulletin.

[2]  W. Streit,et al.  Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions , 1993, Brain Research.

[3]  S. Garattini,et al.  The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat. , 1993, European journal of pharmacology.

[4]  R. Ings,et al.  Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in mouse, rat, dog and man. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  D. McTavish,et al.  Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity. , 1992, Drugs.

[6]  S. Garattini,et al.  Single- and multiple-dose kinetics of d-fenfluramine in rats given anorectic and toxic doses. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  C. Nemeroff,et al.  Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats. , 1991, Endocrinology.

[8]  Michael P. Johnson,et al.  Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine , 1990, Pharmacology Biochemistry and Behavior.

[9]  J. Contrera,et al.  Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data. , 1990, The Journal of pharmacology and experimental therapeutics.

[10]  B. Guy-grand,et al.  INTERNATIONAL TRIAL OF LONG-TERM DEXFENFLURAMINE IN OBESITY , 1989, The Lancet.

[11]  D. Warrell.  CEREBRAL CONSUMPTION OF GLUCOSE - REPLY , 1989 .

[12]  L. J. King,et al.  The measurement of d-fenfluramine and its metabolite, d-norfenfluramine in plasma and urine with an application of the method to pharmacokinetic studies. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[13]  N. Rowland,et al.  Neurobiology of an anorectic drug: Fenfluramine , 1986, Progress in Neurobiology.

[14]  N. Rowland.  Effect of continuous infusions of dexfenfluramine on food intake, body weight and brain amines in rats. , 1986, Life sciences.

[15]  N. Rowland,et al.  Effects of fenfluramine on food intake, body weight, gastric emptying and brain monoamines in syrian hamsters , 1986, Brain Research Bulletin.

[16]  Y. Claustre,et al.  Characterization of [3H]paroxetine binding to rat cortical membranes. , 1985, European journal of pharmacology.

[17]  S. Garattini,et al.  Differences Between d‐Fenfluramine and d‐Norfenfluramine in Serotonin Presynaptic Mechanisms , 1983, Journal of neurochemistry.

[18]  S. Garattini,et al.  Species differences in the kinetics and metabolism of fenfluramine isomers. , 1982, Archives internationales de pharmacodynamie et de therapie.

[19]  S. Thenen,et al.  Fenfluramine Effects on Insulin Resistance and Lipogenesis in Genetically Obese (ob/ob) Mice , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[20]  E. sanders-Bush,et al.  Species differences in the rate of disappearance of fenfluramine and its effects on brain serotonin neurons. , 1979, Biochemical pharmacology.

[21]  S. Thenen,et al.  Effects of Prolonged Fenfluramine Administration in Obese and Nonobese Mice , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[22]  Abdallah Ah.  Comparative study of anorectic activity of d-amphetamine, chlorphentermine and fenfluramine in aurothioglucose obese and non-obese mice. , 1968 .

[23]  J. Blundell,et al.  Pharmacological approaches to appetite suppression. , 1991, Trends in pharmacological sciences.

[24]  N. Rowland,et al.  Long Term Actions of Dexfenfluramine on Food Intake, Body Weight and Brain Serotonin in Rodents , 1990 .

[25]  N. Rowland,et al.  Long term actions of d-fenfluramine in two rat models of obesity. I Sustained reductions in body weight and adiposity without depletion of brain serotonin. , 1989, International journal of obesity.

[26]  C. Bailey,et al.  Anorectic effect of fenfluramine, cholecystokinin and neurotensin in genetically obese (ob/ob) mice. , 1986, Comparative biochemistry and physiology. A, Comparative physiology.

[27]  S. Garattini,et al.  Distribution of fenfluramine in normal and obese mice. , 1978, International journal of obesity.

[28]  E. sanders-Bush,et al.  Long-term effects of continuous exposure to p-chloroamphetamine on central serotonergic mechanisms in mice. , 1978, Biochemical pharmacology.